Inventor · disambiguated record
Gang Hu
Also filed as: HU GANG
1 granted patent·9 pending applications·21 citations·filing 2002–2023
39Inventor score
Files withSICHUAN HAISCO PHARMACEUTICAL CO LTD3XIZANG HAISCO PHARMACEUTICAL CO LTD3REPERTOIRE IMMUNE MEDICINES INC2GENFLEET THERAPEUTICS SHANGHAI INC1INST PHARM & TOXICOLOGY AMMS1
Top patents by PatentIndex Score
10 records- 0177US7560473B2Amine derivative with potassium channel regulatory function, its preparation and useINST PHARM & TOXICOLOGY AMMS·Filed 2002·Granted Jul 14, 2009·21 cites·9 claims
- 0259US2025340532A1Heterocyclic compound ccr4 inhibitor and user thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0355US2024067633A1Ketohexokinase inhibitor and use thereofSICHUAN HAISCO PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0455US2025222116A1Parp-1 degradation agent and use thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0554US2024368204A1Small molecular cd73 antagonist and use thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0653US2023265107A1Pb2 inhibitor, and preparation method therefor and use thereofSICHUAN HAISCO PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0752US2023051239A1Compositions of hydrogels and methods of use thereofREPERTOIRE IMMUNE MEDICINES INC·Filed 2020·Application pending·0 cites
- 0848US2023079045A1Anti-influenza virus compound, preparation method and use thereofSICHUAN HAISCO PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 0945US2022177462A1Substituted heterocyclic amide compound and preparation method therefor and pharmaceutical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2020·Application pending·0 cites
- 1035US2022090297A1Peptide libraries and methods of use thereofREPERTOIRE IMMUNE MEDICINES INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gang Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →